These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34894398)

  • 1.
    Zhang W; Liu Z; Xia S; Yao L; Li L; Gan Z; Tang H; Guo Q; Yan X; Sun Z
    Aging (Albany NY); 2021 Dec; 13(23):25304-25324. PubMed ID: 34894398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
    Ma X; Ding Y; Zeng L
    BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
    Zeng Z; Cao Z; Tang Y
    BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.
    Li S; Huang J; Yang F; Zeng H; Tong Y; Li K
    Sci Rep; 2021 May; 11(1):11078. PubMed ID: 34040099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
    Zeng Z; Cao Z; Zhang E; Huang H; Tang Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.
    Li Y; Gu A; Yang L; Wang Q
    J Cancer Res Clin Oncol; 2024 Sep; 150(9):418. PubMed ID: 39264423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
    Wang J; Huang R; Huang Y; Chen Y; Chen F
    Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
    Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
    Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
    Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Cao L; Cheng H; Jiang Q; Li H; Wu Z
    Aging (Albany NY); 2020 Mar; 12(5):4573-4591. PubMed ID: 32167932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma.
    Liu X; He Y; Wang P; Hu J; Hao C; Wang Q; Yang Y; Sun Y; Ma B; Sun H; Xue D; Meng X
    Dis Markers; 2022; 2022():5791471. PubMed ID: 35280441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Identification of Contradictory Role of ADAMTS5 in Hepatocellular Carcinoma.
    Zhu Z; Xu J; Wu X; Lin S; Li L; Ye W; Huang Z
    Technol Cancer Res Treat; 2021; 20():1533033820986826. PubMed ID: 33522433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
    Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y
    Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.